Goldman Sachs Upgrades Hospira (HSP) to Neutral
Goldman Sachs upgraded Hospira (NYSE: HSP) from Sell to ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
